# Reckitt Benckiser LLC – FDA Inspection, Oct 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/reckitt-benckiser-llc/b3fb10bb-134f-46a9-9bf3-f15ea12b03f0
Source feed: FDA_Inspections

> FDA inspection 1068666 of Reckitt Benckiser LLC, October 12, 2018. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1068666
- Company Name: Reckitt Benckiser LLC
- Inspection Date: 2018-10-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1299424 - 2026-01-20](https://www.keypedia.com/records/fda_inspections/reckitt-benckiser-llc/eb7c325d-603b-477f-a991-92229b3a1c8c)
- FDA Inspection 1211426 - 2023-07-18

## Related Officers

- [Company Rep](https://www.keypedia.com/people/lillie-d-witcher/6e879b86-97a9-48a2-aac6-9f13443b0d17)

Company: https://www.keypedia.com/companies/reckitt-benckiser-llc/120c10ba-ffb3-44d1-b50b-2aa5bbfca96d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
